The University of Helsinki is a public research university located in Helsinki, Finland since 1829, but founded in the city of Turku in 1640 as the Royal Academy of Åbo, at that time part of the Swedish Empire. It is the oldest and largest university in Finland with the widest range of disciplines available.

During the past decade, University of Helsinki conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Helsinki" #1 sponsor was "University of Helsinki" with 9 trials, followed by "Central Finland Hospital District" with 2 trials sponsored, "Clinical Urology and Epidemiology Working Group" with 2 trials sponsored, "Helsinki University Central Hospital" with 2 trials sponsored and "Anne Birgitte Raben" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Helsinki" #1 collaborator was "University of Helsinki" with 8 trials as a collaborator, "Academy of Finland" with 5 trials as a collaborator, "Helsinki University Central Hospital" with 4 trials as a collaborator, "Oulu University Hospital" with 4 trials as a collaborator and "Tampere University Hospital" with 3 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "University of Helsinki" are "Obesity" (3 trials), "Covid19" (2 trials), "Cerebral Hemorrhage" (1 trials), "Coronavirus Disease 2019" (1 trials) and "Dental Crowding" (1 trials). Many other conditions were trialed in "University of Helsinki" in a lesser frequency.

Most popular intervention types in "University of Helsinki" are "Behavioral" (6 trials), "Drug" (5 trials), "Device" (4 trials), "Other" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "'Enjoy your Bump' (iloodottaa.fi) online self-help intervention" (1 trials), "Acromioplasty" (1 trials), "Bright light" (1 trials) and "Conservative treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Helsinki" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Helsinki". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Helsinki, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Helsinki, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".

University of Helsinki has several departments that took part in Clinical trials: "Helsinki University Central Hospital; Dept of Oncology" - 26 trials, "Helsinki University Central Hospital; Rheumatology Clinic" - 4 trials, "Helsinki University Hospital, Dept of Paediatrics" - 2 trials, "Department of Otorhinolaryngology, Helsinki University Hospital" - 2 trials, "Department of Food and Environmental Sciences, University of Helsinki" - 2 trials, "Helsinki University Central Hospital, Psychiatry Centre" - 2 trials, "NEURO" - 2 trials, "Helsinki University Hospital, Dept of Haematology" - 2 trials, "Department of Vascular Surgery, Helsinki University Central Hospital" - 2 trials